Cargando…
Targeting gastrointestinal cancers with chimeric antigen receptor (CAR)-T cell therapy
The immune system is capable of remarkably potent and specific efficacy against infectious diseases. For decades, investigators sought to leverage those characteristics to create immune-based therapies (immunotherapy) that might be far more effective and less toxic than conventional chemotherapy and...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820794/ https://www.ncbi.nlm.nih.gov/pubmed/35129050 http://dx.doi.org/10.1080/15384047.2022.2033057 |